These findings, were consistent with the pivotal role played by DNA ligase III in Alt-NHEJ, an highly error-prone DNA repair pathway, which is strongly involved in the genomic instability, chromosome translocations, and drug resistance of different tumors, such as leukemia, lymphoma, neuroblastoma, and breast cancer [44–47]. Here, LIG3 is linked to leukemia.